Breast radiotherapy accounts for a significant proportion of patient volume in contemporary radiation oncology practice. In the setting of anticipated resource constraints and widespread community infection with SARS-CoV-2 during the COVID-19 pandemic measures for balancing both infectious and oncologic risk among patients and providers must be carefully considered. Here we present evidence-based guidelines for omitting or abbreviating breast cancer radiotherapy where appropriate in an effort to mitigate risk to patients and optimize resource utilization. Breast radiotherapy under COVID-19 pandemic resource constraints -- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States.